MCP-1-bindende Nukleinsäuren
European patent · EP2135949 · Deleted
Register entry
- Publication number
- EP2135949
- Application number
- EP09012826
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Feb 14, 2007
- Published
- Dec 23, 2009
- Granted
- Oct 17, 2012
- Deleted
- Sep 23, 2026
- Reason
- Annual fee unpaid
- IPC classes
- C12N 15/11 (2006.01)A61K 31/7088 (2006.01)
- Priority
- EP 06002935 14.02.2006EP 06024202 22.11.2006
- Divided from
- EP07722818
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 23, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.09.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.09.2026
- Mar 1, 2025
Next annual fee due on
- Next annual fee due on
- 28.02.2025 → 28.02.2026
Published in Swissreg on 01.03.2025
- Mar 1, 2024
Change
Published in Swissreg on 01.03.2024
- Mar 6, 2023
Change
Published in Swissreg on 06.03.2023
- Aug 10, 2022
Address changed
- Owner
- Noxxon Pharma AG, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany → TME Pharma AG, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany
Published in Swissreg on 10.08.2022
- Dec 28, 2012
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 28.12.2012
- Oct 17, 2012
Granted
Published in Swissreg on 17.10.2012
Parties
Inventor
13359 Berlin, DE
13469 Berlin, DE
10247 Berlin, DE
10709 Berlin, DE
14197 Berlin, DE
13509 Berlin, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.